Teriparatide acetate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for teriparatide acetate and what is the scope of patent protection?
Teriparatide acetate
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for teriparatide acetate.
Summary for teriparatide acetate
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 1 |
| Clinical Trials: | 2 |
| DailyMed Link: | teriparatide acetate at DailyMed |
Recent Clinical Trials for teriparatide acetate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Asahi Kasei Pharma Corporation | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for teriparatide acetate
US Patents and Regulatory Information for teriparatide acetate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | PARATHAR | teriparatide acetate | INJECTABLE;INJECTION | 019498-001 | Dec 23, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
